⌘K

Login Start Free

Home/Filings/4/0000899243-19-023128

4//SEC Filing

McMullin David 4

Accession 0000899243-19-023128

CIK 0001341235other

View on SEC.gov Company Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 4:37 PM ET

Size

4.9 KB

Accession

0000899243-19-023128

Insider Transaction Report

Form 4

Period: 2019-09-05

Aldeyra Therapeutics, Inc.ALDX

SVP Corp. Dev. & Strategy

Transactions

Purchase
Common Stock
2019-09-05$4.68/sh+4,329$20,260→ 6,148 total

Footnotes (1)

[F1]Includes 1,819 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Aldeyra Therapeutics, Inc.

CIK 0001341235

Entity typeother

Related Parties

1

filerCIK 0001738662

Filing Metadata

Form type: 4
Filed: Sep 8, 8:00 PM ET
Accepted: Sep 9, 4:37 PM ET
Size: 4.9 KB

View on SEC.gov